International Society of Sports Nutrition position stand: creatine supplementation and exercise by Buford, Thomas W et al.
BioMed  Central
Page 1 of 8
(page number not for citation purposes)
Journal of the International Society 
of Sports Nutrition
Open Access Commentary
International Society of Sports Nutrition position stand: creatine 
supplementation and exercise
Thomas W Buford, Richard B Kreider*, Jeffrey R Stout, Mike Greenwood, 
Bill Campbell, Marie Spano, Tim Ziegenfuss, Hector Lopez, Jamie Landis and 
Jose Antonio
Address: International Society of Sports Nutrition, 600 Pembrook Drive, Woodland Park, CO 80863, USA
Email: Thomas W Buford - thomas_buford@baylor.edu; Richard B Kreider* - Richard_Kreider@baylor.edu; Jeffrey R Stout - jrstout@ou.edu; 
Mike Greenwood - Mike_Greenwood@baylor.edu; Bill Campbell - Campbell@coedu.usf.edu; Marie Spano - mariespano@comcast.net; 
Tim Ziegenfuss - tim@ohioresearchgroup.com; Hector Lopez - hlopezmd@gmail.com; Jamie Landis - jlandis@lakelandcc.edu; 
Jose Antonio - exphys@aol.com
* Corresponding author    
A Position Statement and Review of the 
Literature
Position Statement: The following nine points related
to the use of creatine as a nutritional supplement con-
stitute the Position Statement of the Society. They have
been approved by the Research Committee of the Soci-
ety.
1. Creatine monohydrate is the most effective ergogenic
nutritional supplement currently available to athletes in
terms of increasing high-intensity exercise capacity and
lean body mass during training.
2. Creatine monohydrate supplementation is not only
safe, but possibly beneficial in regard to preventing injury
and/or management of select medical conditions when
taken within recommended guidelines.
3. There is no scientific evidence that the short- or long-
term use of creatine monohydrate has any detrimental
effects on otherwise healthy individuals.
4. If proper precautions and supervision are provided,
supplementation in young athletes is acceptable and may
provide a nutritional alternative to potentially dangerous
anabolic drugs.
5. At present, creatine monohydrate is the most exten-
sively studied and clinically effective form of creatine for
use in nutritional supplements in terms of muscle uptake
and ability to increase high-intensity exercise capacity.
6. The addition of carbohydrate or carbohydrate and pro-
tein to a creatine supplement appears to increase muscu-
lar retention of creatine, although the effect on
performance measures may not be greater than using cre-
atine monohydrate alone.
7. The quickest method of increasing muscle creatine
stores appears to be to consume ~0.3 grams/kg/day of cre-
atine monohydrate for at least 3 days followed by 3–5 g/
d thereafter to maintain elevated stores. Ingesting smaller
amounts of creatine monohydrate (e.g., 2–3 g/d) will
increase muscle creatine stores over a 3–4 week period,
however, the performance effects of this method of sup-
plementation are less supported.
8. Creatine products are readily available as a dietary sup-
plement and are regulated by the U.S. Food and Drug
Administration (FDA). Specifically, in 1994, U.S. President
Bill Clinton signed into law the Dietary Supplement
Health and Education Act (DSHEA). DSHEA allows man-
ufacturers/companies/brands to make structure-function
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claims; however, the law strictly prohibits disease claims
for dietary supplements.
9. Creatine monohydrate has been reported to have a
number of potentially beneficial uses in several clinical
populations, and further research is warranted in these
areas.
The following literature review has been prepared by the
authors in support of the aforementioned position state-
ment.
Creatine Supplementation and Exercise: A 
Review of the Literature
Introduction
The use of creatine as a sport supplement has been sur-
rounded by both controversy and fallacy since it gained
widespread popularity in the early 1990's. Anecdotal and
media reports have often claimed that creatine usage is a
dangerous and unnecessary practice; often linking creat-
ine use to anabolic steroid abuse [1]. Many athletes and
experts in the field have reported that creatine supplemen-
tation is not only beneficial for athletic performance and
various medical conditions but is also clinically safe [2-5].
Although creatine has recently been accepted as a safe and
useful ergogenic aid, several myths have been purported
about creatine supplementation which include:
1. All weight gained during supplementation is due to
water retention.
2. Creatine supplementation causes renal distress.
3. Creatine supplementation causes cramping, dehydra-
tion, and/or altered electrolyte status.
4. Long-term effects of creatine supplementation are com-
pletely unknown.
5. Newer creatine formulations are more beneficial than
creatine monohydrate (CM) and cause fewer side effects.
6. It's unethical and/or illegal to use creatine supplements.
While these myths have been refuted through scientific
investigation, the general public is still primarily exposed
to the mass media which may or may not have accurate
information. Due to this confounding information, com-
bined with the fact that creatine has become one of the
most popular nutritional supplements on the market, it is
important to examine the primary literature on supple-
mental creatine ingestion in humans. The purpose of this
review is to determine the present state of knowledge con-
cerning creatine supplementation, so that reasonable
guidelines may be established and unfounded fears
diminished in regard to its use.
Background
Creatine has become one of the most extensively studied
and scientifically validated nutritional ergogenic aids for
athletes. Additionally, creatine has been evaluated as a
potential therapeutic agent in a variety of medical condi-
tions such as Alzheimer's and Parkinson's diseases. Bio-
chemically speaking, the energy supplied to
rephosphorylate adenosine diphosphate (ADP) to adeno-
sine triphosphate (ATP) during and following intense
exercise is largely dependent on the amount of phospho-
creatine (PCr) stored in the muscle [6,7]. As PCr stores
become depleted during intense exercise, energy availabil-
ity diminishes due to the inability to resynthesize ATP at
the rate required to sustained high-intensity exercise [6,7].
Consequently, the ability to maintain maximal-effort
exercise declines. The availability of PCr in the muscle
may significantly influence the amount of energy gener-
ated during brief periods of high-intensity exercise. Fur-
thermore, it has been hypothesized that increasing muscle
creatine content, via creatine supplementation, may
increase the availability of PCr allowing for an accelerated
rate of resynthesis of ATP during and following high-
intensity, short-duration exercise [6-12]. Theoretically,
creatine supplementation during training may lead to
greater training adaptations due to an enhanced quality
and volume of work performed. In terms of potential
medical applications, creatine is intimately involved in a
number of metabolic pathways. For this reason, medical
researchers have been investigating the potential thera-
peutic role of creatine supplementation in a variety of
patient populations.
Creatine is chemically known as a non-protein nitrogen; a
compound which contains nitrogen but is not a protein
per se [13]. It is synthesized in the liver and pancreas from
the amino acids arginine, glycine, and methionine
[9,13,14]. Approximately 95% of the body's creatine is
stored in skeletal muscle. Additionally, small amounts of
creatine are also found in the brain and testes [8,15].
About two thirds of the creatine found in skeletal muscle
is stored as phosphocreatine (PCr) while the remaining
amount of creatine is stored as free creatine [8]. The total
creatine pool (PCr + free creatine) in skeletal muscle aver-
ages about 120 grams for a 70 kg individual. However, the
average human has the capacity to store up to 160 grams
of creatine under certain conditions [7,9]. The body
breaks down about 1 – 2% of the creatine pool per day
(about 1–2 grams/day) into creatinine in the skeletal
muscle [13]. The creatinine is then excreted in urine
[13,16]. Creatine stores can be replenished by obtaining
creatine in the diet or through endogenous synthesis of
creatine from glycine, arginine, and methionine [17,18].Journal of the International Society of Sports Nutrition 2007, 4:6 http://www.jissn.com/content/4/1/6
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Dietary sources of creatine include meats and fish. Large
amounts of fish and meat must be consumed in order to
obtain gram quantities of creatine. Whereas dietary sup-
plementation of creatine provides an inexpensive and effi-
cient means of increasing dietary availability of creatine
without excessive fat and/or protein intake.
Supplementation Protocols and Effects on Muscle 
Creatine Stores
Various supplementation protocols have been suggested
to be efficacious in increasing muscle stores of creatine.
The amount of increase in muscle storage depends on the
levels of creatine in the muscle prior to supplementation.
Those who have lower muscle creatine stores, such as
those who eat little meat or fish, are more likely to experi-
ence muscle storage increases of 20–40%, whereas those
with relatively high muscle stores may only increase stores
by 10–20% [19]. The magnitude of the increase in skeletal
muscle creatine content is important because studies have
reported performance changes to be correlated to this
increase [20,21].
The supplementation protocol most often described in
the literature is referred to as the "loading" protocol. This
protocol is characterized by ingesting approximately 0.3
grams/kg/day of CM for 5 – 7 days (e.g., 5 grams taken
four times per day) and 3–5 grams/day thereafter [18,22].
Research has shown a 10–40% increase in muscle creatine
and PCr stores using this protocol [10,22]. Additional
research has reported that the loading protocol may only
need to be 2–3 days in length to be beneficial, particularly
if the ingestion coincides with protein and/or carbohy-
drate [23,24]. Furthermore, supplementing with 0.25
grams/kg-fat free mass/day of CM may be an alternative
dosage sufficient to increase muscle creatine stores [25].
Other suggested supplementation protocols utilized
include those with no loading phase as well as "cycling"
strategies. A few studies have reported protocols with no
loading period to be sufficient for increasing muscle crea-
tine (3 g/d for 28 days) [15] as well as muscle size and
strength (6 g/d for 12 weeks) [26,27]. These protocols
seems to be equally effective in increasing muscular stores
of creatine, but the increase is more gradual and thus the
ergogenic effect does not occur as quickly. Cycling proto-
cols involve the consumption of "loading" doses for 3–5
days every 3 to 4 weeks [18,22]. These cycling protocols
appear to be effective in increasing and maintaining mus-
cle creatine content before a drop to baseline values,
which occurs at about 4–6 weeks [28,29].
Creatine Formulations and Combinations
Many forms of creatine exist in the marketplace, and these
choices can be very confusing for the consumer. Some of
these formulations and combinations include creatine
phosphate, creatine + β-hydroxy-β-methlybutyrate
(HMB), creatine + sodium bicarbonate, creatine magne-
sium-chelate, creatine + glycerol, creatine + glutamine,
creatine + β-alanine, creatine ethyl ester, creatine with cin-
nulin extract, as well as "effervescent" and "serum formu-
lations". Most of these forms of creatine have been
reported to be no better than traditional CM in terms of
increasing strength or performance [30-38]. Reliable stud-
ies are yet to be published for creatine ethyl ester and cre-
atine with cinnulin extract. Recent studies do suggest,
however, that adding β-alanine to CM may produce
greater effects than CM alone. These investigations indi-
cate that the combination may have greater effects on
strength, lean mass, and body fat percentage; in addition
to delaying neuromuscular fatigue [31,32].
Three alternative creatine formulations have shown
promise, but at present do not have sufficient evidence to
warrant recommendation in lieu of CM. For example, cre-
atine phosphate has been reported to be as effective as CM
at improving LBM and strength, [36] yet this has only
been reported in one study. In addition, creatine phos-
phate is currently more difficult and expensive to produce
than CM. Combining CM with sodium phosphate, which
has been reported to enhance high-intensity endurance
exercise, may be a more affordable alternative to creatine
phosphate. Secondly, a creatine/HMB combination was
reported to be more effective at improving LBM and
strength than either supplement alone [39], but other data
has reported the combination offers no benefit in terms of
increasing aerobic or anaerobic capacity [40,41]. The con-
flicting data therefore do not warrant recommendation of
the creatine/HMB combination in lieu of CM. Lastly, cre-
atine + glycerol has been reported to increase total body
water as a hyper-hydration method prior to exercise in the
heat, but this is also the first study of its kind. In addition,
this combination failed to improve thermal and cardio-
vascular responses to a greater extent than CM alone [42].
The addition of nutrients that increase insulin levels and/
or improve insulin sensitivity has been a major source of
interest in the last few years by scientists looking to opti-
mize the ergogenic effects of creatine. The addition of cer-
tain macronutrients appears to significantly augment
muscle retention of creatine. Green et al. [24] reported
that adding 93 g of carbohydrate to 5 g of CM increased
total muscle creatine by 60%. Likewise, Steenge et al. [23]
reported that adding 47 g of carbohydrate and 50 g of pro-
tein to CM was as effective at promoting muscle retention
of creatine as adding 96 g of carbohydrate. Additional
investigations by Greenwood and colleagues [30,43] have
reported increased creatine retention from the addition of
dextrose or low levels of D-pinitol (a plant extract with
insulin-like properties). While the addition of these nutri-
ents has proved to increase muscle retention, severalJournal of the International Society of Sports Nutrition 2007, 4:6 http://www.jissn.com/content/4/1/6
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recent investigations have reported these combinations to
be no more effective at improving muscle strength and
endurance or athletic performance [44-46]. Other recent
studies, however, have indicated a potential benefit on
anaerobic power, muscle hypertrophy, and 1 RM muscle
strength when combining protein with creatine [47,48]. It
appears that combining CM with carbohydrate or carbo-
hydrate and protein produces optimal results. Studies sug-
gest that increasing skeletal muscle creatine uptake may
enhance the benefits of training.
Effects of Supplementation on Exercise Performance and 
Training Adaptations
CM appears to be the most effective nutritional supple-
ment currently available in terms of improving lean body
mass and anaerobic capacity. To date, several hundred
peer-reviewed research studies have been conducted to
evaluate the efficacy of CM supplementation in improv-
ing exercise performance. Nearly 70% of these studies
have reported a significant improvement in exercise
capacity, while the others have generally reported non-sig-
nificant gains in performance [49]. No studies have
reported an ergolytic effect on performance although
some have suggested that weight gain associated with CM
supplementation could be detrimental in sports such as
running or swimming. The average gain in performance
from these studies typically ranges between 10 to 15%
depending on the variable of interest. For example, short-
term CM supplementation has been reported to improve
maximal power/strength (5–15%), work performed dur-
ing sets of maximal effort muscle contractions (5–15%),
single-effort sprint performance (1–5%), and work per-
formed during repetitive sprint performance (5–15%)
[49]. Long-term CM supplementation appears to enhance
the overall quality of training, leading to 5 to 15% greater
gains in strength and performance [49]. Nearly all studies
indicate that "proper" CM supplementation increases
body mass by about 1 to 2 kg in the first week of loading
[19].
The vast expanse of literature confirming the effectiveness
of CM supplementation is far beyond the scope of this
review. Briefly, short-term adaptations reported from CM
supplementation include increased cycling power, total
work performed on the bench press and jump squat, as
well as improved sport performance in sprinting, swim-
ming, and soccer [38,50-57]. Long-term adaptations
when combining CM supplementation with training
include increased muscle creatine and PCr content, lean
body mass, strength, sprint performance, power, rate of
force development, and muscle diameter [39,54-60]. In
long-term studies, subjects taking CM typically gain about
twice as much body mass and/or fat free mass (i.e., an
extra 2 to 4 pounds of muscle mass during 4 to 12 weeks
of training) than subjects taking a placebo [61-64]. The
gains in muscle mass appear to be a result of an improved
ability to perform high-intensity exercise via increased PCr
availability and enhanced ATP synthesis, thereby enabling
an athlete to train harder and promote greater muscular
hypertrophy via increased myosin heavy chain expression
possibly due to an increase in myogenic regulatory factors
myogenin and MRF-4 [26,27,65]. The tremendous num-
bers of investigations conducted with positive results from
CM supplementation lead us to conclude that it is the
most effective nutritional supplement available today for
increasing high-intensity exercise capacity and building
lean mass.
Medical Safety of Creatine Supplementation
While the only clinically significant side effect reported in
the research literature is that of weight gain [4,18,22],
many anecdotal claims of side effects including dehydra-
tion, cramping, kidney and liver damage, musculoskeletal
injury, gastrointestinal distress, and anterior (leg) com-
partment syndrome still exist in the media and popular
literature. While athletes who are taking CM may experi-
ence these symptoms, the scientific literature suggests that
these athletes have no greater, and a possibly lower, risk of
these symptoms than those not supplementing with CM
[2,4,66,67].
Many of these fears have been generated by the media and
data taken from case studies (n = 1). Poortmans and Fran-
caux reported that the claims of deleterious effects of cre-
atine supplements on renal function began in 1998 [68].
These claims followed a report that creatine supplementa-
tion was detrimental to renal glomerular filtration rate
(GFR) in a 25-year-old man who had previously presented
with kidney disease (glomerulosclerosis and corticoster-
oid-responsive nephritic syndrome) [69]. Three days later,
a French sports newspaper, L'Equipe, reported that supple-
mental creatine is dangerous for the kidneys in any condi-
tion [70]. Several European newspapers then picked up
the "news" and reported the same. Since that time, other
individual case studies have been published posing that
CM supplementation caused deleterious effects on renal
function [71,72].
Much of the concern about CM supplementation and
renal function has centered around concerns over
increased serum creatinine levels. While creatinine does
make up a portion of GFR and must be excreted by the
kidneys, there is no evidence to support the notion that
normal creatine intakes (< 25 g/d) in healthy adults cause
renal dysfunction. In fact, Poortmans et al. have shown no
detrimental effects of short- (5 days), medium- (14 days),
or long-term (10 months to 5 years) CM supplementation
on renal function [5,73,74]. Interestingly, Kreider et al. [4]
observed no significant difference in creatinine levels
between CM users and controls, yet most athletes (regard-Journal of the International Society of Sports Nutrition 2007, 4:6 http://www.jissn.com/content/4/1/6
Page 5 of 8
(page number not for citation purposes)
less of whether taking CM or not) had elevated creatinine
levels along with proper clearance during intense training.
The authors noted that if serum creatinine was examined
as the sole measure of renal function, it would appear that
nearly all of the athletes (regardless of CM usage) were
experiencing renal distress. Although case studies have
reported problems, these large-scale, controlled studies
have shown no evidence indicating that CM supplemen-
tation in healthy individuals is a detriment to kidney func-
tioning.
Another anecdotal complaint about supplemental creat-
ine is that the long-term effects are not known. Wide-
spread use of CM began in the 1990's. Over the last few
years a number of researchers have begun to release results
of long-term safety trials. So far, no long-term side effects
have been observed in athletes (up to 5 years), infants
with creatine synthesis deficiency (up to 3 years), or in
clinical patient populations (up to 5 years)
[4,5,18,75,76]. One cohort of patients taking 1.5 – 3
grams/day of CM has been monitored since 1981 with no
significant side effects [77,78]. In addition, research has
demonstrated a number of potentially helpful clinical
uses of CM in heart patients, infants and patients with cre-
atine synthesis deficiency, patients suffering orthopedic
injury, and patients with various neuromuscular diseases.
Potential medical uses of supplemental creatine have
been investigated since the mid 1970s. Initially, research
focused on the role of CM and/or creatine phosphate in
reducing heart arrhythmias and/or improving heart func-
tion during ischemic events [18]. Interest in medical uses
of creatine supplements has expanded to include those
with creatine deficiencies [79-81], brain and/or spinal
cord injuries [82-86], muscular dystrophy [87-90], diabe-
tes [91], high cholesterol/triglyceride levels [92], and pul-
monary disease [93] among others. Although more
research is needed to determine the extent of the clinical
utility, some promising results have been reported in a
number of studies suggesting that creatine supplements
may have therapeutic benefit in certain patient popula-
tions. In conjunction with short- and long-term studies in
healthy populations, this evidence suggests that creatine
supplementation appears to be safe when taken within
recommended usage guidelines.
Creatine Use in Children and Adolescents
Opponents of creatine supplementation have claimed
that it is not safe for children and adolescents [1]. While
fewer investigations have been conducted in using
younger participants, no study has shown CM to have
adverse effects in children. In fact, long-term CM supple-
mentation (e.g., 4 – 8 grams/day for up to 3 years) has
been used as an adjunctive therapy for a number of creat-
ine synthesis deficiencies and neuromuscular disorders in
children. Clinical trials are also being conducted in chil-
dren with Duschenne muscular dystrophy [87,88]. How-
ever, as less is known about the effects of supplemental
creatine on children and adolescents, it is the view of the
ISSN that younger athletes should consider a creatine sup-
plement only if the following conditions are met [19]:
1. The athlete is past puberty and is involved in serious/
competitive training that may benefit from creatine sup-
plementation;
2. The athlete is eating a well-balanced, performance-
enhancing diet;
3. The athlete and his/her parents understand the truth
concerning the effects of creatine supplementation;
4. The athlete's parents approve that their child takes sup-
plemental creatine;
5. Creatine supplementation can be supervised by the ath-
letes parents, trainers, coaches, and/or physician;
6. Quality supplements are used; and,
7. The athlete does not exceed recommended dosages.
If these conditions are met, then it would seem reasonable
that high school athletes should be able to take a creatine
supplement. Doing so may actually provide a safe nutri-
tional alternative to illegal anabolic steroids or other
potentially harmful drugs. Conversely, if the above condi-
tions are not met, then creatine supplementation may not
be appropriate. It appears that this is no different than
teaching young athletes' proper training and dietary strat-
egies to optimize performance. Creatine is not a panacea
or short cut to athletic success. It can, however, offer some
benefits to optimize training of athletes involved in
intense exercise in a similar manner that ingesting a high-
carbohydrate diet, sports drinks, and/or carbohydrate
loading can optimize performance of an endurance ath-
lete.
The Ethics of Creatine
Several athletic governing bodies and special interest
groups have questioned whether it is ethical for athletes to
take creatine supplements as a method of enhancing per-
formance. Since research indicates that CM can improve
performance, and it would be difficult to ingest enough
creatine from food in the diet, they rationalize that it is
unethical to do so. In this age of steroid suspicion in
sports, some argue that if you allow athletes to take creat-
ine, they may be more predisposed to try other dangerous
supplements and/or drugs. Still others have attempted to
directly lump creatine in with anabolic steroids and/or
banned stimulants and have called for a ban on the use ofJournal of the International Society of Sports Nutrition 2007, 4:6 http://www.jissn.com/content/4/1/6
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CM and other supplements among athletes. Finally, fresh
off of the ban of dietary supplements containing ephedra,
some have called for a ban on the sale of CM citing safety
concerns. Creatine supplementation is not currently
banned by any athletic organization although the NCAA
does not allow institutions to provide CM or other "mus-
cle building" supplements to their athletes (e.g., protein,
amino acids, HMB, etc). In this case, athletes must pur-
chase creatine containing supplements on their own. The
International Olympic Committee considered these argu-
ments and ruled that there was no need to ban creatine
supplements since creatine is readily found in meat and
fish and there is no valid test to determine whether ath-
letes are taking it. In light of the research that has been
conducted with CM, it appears that those who call for a
ban on it are merely familiar with the anecdotal myths
surrounding the supplement, and not the actual facts. We
see no difference between creatine supplementation and
ethical methods of gaining athletic advantage such as
using advanced training techniques and proper nutri-
tional methods. Carbohydrate loading is a nutritional
technique used to enhance performance by enhancing
glycogen stores. We see no difference between such a prac-
tice and supplementing with creatine to enhance skeletal
muscle creatine and PCr stores. If anything, it could be
argued that banning the use of creatine would be unethi-
cal as it has been reported to decrease the incidence of
musculoskeletal injuries [2,66,75,94], heat stress
[2,95,96], provide neuroprotective effects
[82,83,85,97,98], and expedite rehabilitation from injury
[86,99,100].
Conclusion
It is the position of the International Society of Sports
Nutrition that the use of creatine as a nutritional supple-
ment within established guidelines is safe, effective, and
ethical. Despite lingering myths concerning creatine sup-
plementation in conjunction with exercise, CM remains
one of the most extensively studied, as well as effective,
nutritional aids available to athletes. Hundreds of studies
have shown the effectiveness of CM supplementation in
improving anaerobic capacity, strength, and lean body
mass in conjunction with training. In addition, CM has
repeatedly been reported to be safe, as well as possibly
beneficial in preventing injury. Finally, the future of crea-
tine research looks bright in regard to the areas of trans-
port mechanisms, improved muscle retention, as well as
treatment of numerous clinical maladies via supplemen-
tation.
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